Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Anticancer Research|July 9, 2011
Induction treatment for diffuse intrinsic pontine glioma, experience of M.D. Anderson Cancer CenterJohannes E Wolff, Michael Rytting, Tribhawa Vats, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Human Pathology|November 3, 2010
TMPRSS2-ERG gene fusion in small cell carcinoma of the prostateCharles C Guo, Jane Y Dancer, Yan Wang, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Cancer|November 17, 2011
Durable remission with salvage second autotransplants in patients with multiple myelomaNina Shah, Fraz Ahmed, Qaiser Bashir, et al.
Annals of Surgical Oncology|October 28, 2008
A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosisJohn C McAuliffe, Kelly K Hunt, Alexander J F Lazar, et al.
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
Pageof 20